489 related articles for article (PubMed ID: 26687041)
1. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
[TBL] [Abstract][Full Text] [Related]
3. Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
Breault SR; Heye T; Bashir MR; Dale BM; Merkle EM; Reiner CS; Faridi KF; Gupta RT
AJR Am J Roentgenol; 2013 Mar; 200(3):W297-303. PubMed ID: 23436875
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.
Davenport MS; Heye T; Dale BM; Horvath JJ; Breault SR; Feuerlein S; Bashir MR; Boll DT; Merkle EM
J Magn Reson Imaging; 2013 Aug; 38(2):329-35. PubMed ID: 23239041
[TBL] [Abstract][Full Text] [Related]
5. Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value.
Heye T; Boll DT; Reiner CS; Bashir MR; Dale BM; Merkle EM
J Magn Reson Imaging; 2014 May; 39(5):1136-45. PubMed ID: 25006630
[TBL] [Abstract][Full Text] [Related]
6. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
[TBL] [Abstract][Full Text] [Related]
7. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
8. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
Nadav G; Liberman G; Artzi M; Kiryati N; Bashat DB
J Magn Reson Imaging; 2017 Jan; 45(1):237-249. PubMed ID: 27383624
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.
Sun H; Xu Y; Xu Q; Duan J; Zhang H; Liu T; Li L; Chan Q; Xie S; Wang W
Acad Radiol; 2019 Jul; 26(7):e134-e140. PubMed ID: 30268719
[TBL] [Abstract][Full Text] [Related]
10. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness.
Sanz-Requena R; Martí-Bonmatí L; Pérez-Martínez R; García-Martí G
Eur J Radiol; 2016 Nov; 85(11):2119-2126. PubMed ID: 27776667
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
13. Cluster analysis of DCE-MRI data identifies regional tracer-kinetic changes after tumor treatment with high intensity focused ultrasound.
Jacobs I; Hectors SJ; Schabel MC; Grüll H; Strijkers GJ; Nicolay K
NMR Biomed; 2015 Nov; 28(11):1443-54. PubMed ID: 26390040
[TBL] [Abstract][Full Text] [Related]
14. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
[TBL] [Abstract][Full Text] [Related]
15. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
16. Semiautomatic determination of arterial input functions for quantitative dynamic contrast-enhanced magnetic resonance imaging in non-small cell lung cancer patients.
Chung J; Kim JH; Lee EJ; Kim YN; Yi CA
Invest Radiol; 2015 Mar; 50(3):129-34. PubMed ID: 25369854
[TBL] [Abstract][Full Text] [Related]
17. Optimization of saturation-recovery dynamic contrast-enhanced MRI acquisition protocol: monte carlo simulation approach demonstrated with gadolinium MR renography.
Zhang JL; Conlin CC; Carlston K; Xie L; Kim D; Morrell G; Morton K; Lee VS
NMR Biomed; 2016 Jul; 29(7):969-77. PubMed ID: 27200499
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
19. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
[TBL] [Abstract][Full Text] [Related]
20. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
